May 30, 2003
1 min read
Save

Amniotic membrane transplant improves keratitis locally in animal study

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Ulcerating herpetic keratitis improved markedly after amniotic membrane transplantation in an animal study. The effects were thought by researchers to be local, not systemic.

A. Heiligenhaus and colleagues at the University Eye Clinic in Essen, Germany, infected the corneas of mice with herpes simplex virus-1. The mice with ulcerating keratitis on day 14 were divided into four groups, treated with either amniotic membrane transplant or tarsorrhaphy, either alone or in different combinations between eyes.

Ulceration and stromal inflammation were profoundly improved in the eyes treated with amniotic membrane transplant over those treated with tarsorrhaphy. The corneas of the AMT-treated mice had fewer inflammatory cells, CD3+, CD4+ and CD8+ cells than the control mice.

Having tarsorrhaphy or AMT in the fellow eye had no influence on the course of the ulceration, suggesting a local rather than systemic effect of AMT.

The study is published in Der Ophthalmologe.